CME Group Inc. (CME)
Markets Attempt to Rebound from Correction: Here's What to Do
Fears are lingering in a sign that market participants remain concerned about tariffs and broader economic weakness.
CME (CME) Up 3.9% Since Last Earnings Report: Can It Continue?
CME (CME) reported earnings 30 days ago. What's next for the stock?
CME Group (CME) Is Up 0.32% in One Week: What You Should Know
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
CME (CME) Upgraded to Buy: Here's Why
CME (CME) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Interest Rates Are Now Expected to Fall Rapidly in 2025 – Here's What It Means to You
At the start of 2025, the general expectation was that we'd see maybe one or two interest rate cuts from the Federal Reserve. However, in recent weeks, expectations have changed dramatically.
The Zacks Analyst Blog Coinbase, Cipher, CME, Amazon and NVIDIA
Coinbase, Cipher, CME, Amazon and NVIDIA are included in this Analyst Blog.
Zacks Industry Outlook Intercontinental Exchange, CME, Nasdaq, Cboe Global Markets
Intercontinental Exchange, CME, Nasdaq, Cboe Global Markets have been highlighted in this Industry Outlook article.
Has CME Group (CME) Outpaced Other Finance Stocks This Year?
Here is how CME Group (CME) and Main Street Capital (MAIN) have performed compared to their sector so far this year.
CME Group: High Quality With Good Dividend Yield
CME Group's near-monopoly in futures and options trading, with extraordinary 60% FCF margins, makes it a high-quality, capital-light business despite regulatory costs. Significant acquisitions like CBOT, NYMEX, and KCBT have solidified CME's market dominance, though future focus will be on dividends and smaller acquisitions. CME is slightly undervalued with a 4% dividend yield, making it a strong hold for dividend-focused investors seeking a high-quality business model.
CME Group: A High-Quality Dividend Grower Available At Fair Value
CME Group has a dividend yield and a P/E ratio of 23.71, with a robust 10-year growth rate of 8%. The stock appears undervalued due to its strong balance sheet and market moat, presenting a potential buying opportunity. CME Group owns the world's largest derivatives exchanges, including CME, NYMEX, and COMEX, enhancing its market position.
CME Group Q4 Earnings and Revenues Beat Estimates, Rise Y/Y
CME's quarterly results benefit from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees.
CME Group Inc. (CME) Q4 2024 Earnings Call Transcript
CME Group Inc. (NASDAQ:CME ) Q4 2024 Earnings Conference Call February 12, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Lynne Fitzpatrick - Chief Financial Officer Julie Winkler - Chief Commercial Officer Derek Sammann - Global Head, Commodities Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Tim McCourt - Global Head, Equities, FX & Alternative Products Mike Dennis - Global Head, Fixed Income Conference Call Participants Patrick Moley - Piper Sandler Alex Kramm - UBS Michael Cyprys - Morgan Stanley Benjamin Budish - Barclays Capital Chris Allen - Citi Dan Fannon - Jefferies Brian Bedell - Deutsche Bank Bill Katz - TD Cowen Owen Lau - Oppenheimer Kyle Voigt - KBW Madeline Daleiden - JPMorgan Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group Fourth Quarter 2024 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
